Treatment For Parkinson Disease Articles & Analysis: Older
4 news found
INBRIJA is indicated in the United States for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson's disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor. ...
Molomics has used this approach toward advancing the treatment of Parkinson's Disease to develop a drug that addresses Levadopa Induced Dyskinesia, a movement disorder that affects Parkinson patients. Molomics’ technology will seamlessly integrate into VeriSIM’s 'virtual drug development engine', BIOiSIM™, to ...
The technology will be initially applied to Parkinson patients, although other indications will be pursued in the future. ...
"This new MJFF grant has been awarded following the success of our Parkinson's disease project over the past year, and provides recognition of our innovative V-Smart™ drug delivery system and its potential to transform the treatment of Parkinson's disease with an effective therapeutic that overcomes the ...